Nurwidya Fariz, Takahashi Fumiyuki, Kobayashi Isao, Murakami Akiko, Kato Motoyasu, Minakata Kunihiko, Nara Takeshi, Hashimoto Muneaki, Yagishita Shigehiro, Baskoro Hario, Hidayat Moulid, Shimada Naoko, Takahashi Kazuhisa
Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Ages, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):332-8. doi: 10.1016/j.bbrc.2014.11.014. Epub 2014 Nov 15.
Insulin-like growth factor 1 receptor (IGF1R) is expressed in many types of solid tumors including non-small cell lung cancer (NSCLC), and enhanced activation of IGF1R is thought to reflect cancer progression. Epithelial-mesenchymal transition (EMT) has been established as one of the mechanisms responsible for cancer progression and metastasis, and microenvironment conditions, such as hypoxia, have been shown to induce EMT. The purposes of this study were to address the role of IGF1R activation in hypoxia-induced EMT in NSCLC and to determine whether inhibition of IGF1R might reverse hypoxia-induced EMT. Human NSCLC cell lines A549 and HCC2935 were exposed to hypoxia to investigate the expression of EMT-related genes and phenotypes. Gene expression analysis was performed by quantitative real-time PCR and cell phenotypes were studied by morphology assessment, scratch wound assay, and immunofluorescence. Hypoxia-exposed cells exhibited a spindle-shaped morphology with increased cell motility reminiscent of EMT, and demonstrated the loss of E-cadherin and increased expression of fibronectin and vimentin. Hypoxia also led to increased expression of IGF1, IGF binding protein-3 (IGFBP3), and IGF1R, but not transforming growth factor β1 (TGFβ1). Inhibition of hypoxia-inducible factor 1α (HIF1α) with YC-1 abrogated activation of IGF1R, and reduced IGF1 and IGFBP3 expression in hypoxic cells. Furthermore, inhibition of IGF1R using AEW541 in hypoxic condition restored E-cadherin expression, and reduced expression of fibronectin and vimentin. Finally, IGF1 stimulation of normoxic cells induced EMT. Our findings indicated that hypoxia induced EMT in NSCLC cells through activation of IGF1R, and that IGF1R inhibition reversed these phenomena. These results suggest a potential role for targeting IGF1R in the prevention of hypoxia-induced cancer progression and metastasis mediated by EMT.
胰岛素样生长因子1受体(IGF1R)在包括非小细胞肺癌(NSCLC)在内的多种实体瘤中表达,IGF1R的激活增强被认为反映了癌症进展。上皮-间质转化(EMT)已被确认为癌症进展和转移的机制之一,并且诸如缺氧等微环境条件已被证明可诱导EMT。本研究的目的是探讨IGF1R激活在NSCLC缺氧诱导的EMT中的作用,并确定抑制IGF1R是否可能逆转缺氧诱导的EMT。将人NSCLC细胞系A549和HCC2935暴露于缺氧环境中,以研究EMT相关基因的表达和表型。通过定量实时PCR进行基因表达分析,并通过形态学评估、划痕试验和免疫荧光研究细胞表型。暴露于缺氧环境的细胞呈现纺锤形形态,细胞运动性增加,让人联想到EMT,并表现出E-钙黏蛋白的丢失以及纤连蛋白和波形蛋白表达的增加。缺氧还导致IGF1、胰岛素样生长因子结合蛋白3(IGFBP3)和IGF1R的表达增加,但转化生长因子β1(TGFβ1)的表达未增加。用YC-1抑制缺氧诱导因子1α(HIF1α)可消除IGF1R的激活,并降低缺氧细胞中IGF1和IGFBP3的表达。此外,在缺氧条件下使用AEW541抑制IGF1R可恢复E-钙黏蛋白的表达,并降低纤连蛋白和波形蛋白的表达。最后,用IGF1刺激常氧细胞可诱导EMT。我们的研究结果表明,缺氧通过激活IGF1R诱导NSCLC细胞发生EMT,并且抑制IGF1R可逆转这些现象。这些结果表明,靶向IGF1R在预防由EMT介导的缺氧诱导的癌症进展和转移中具有潜在作用。